-
摘要: Castleman病和POEMS综合征属于罕见病, 二者关系密切, 但临床对其肾脏损伤认识不多。本例患者为44岁男性, 病初表现为顽固性腹腔积液, 之后出现肾功能异常及下肢水肿, 查体发现颈胸部多发血管瘤, 炎症指标及血清血管内皮生长因子明显升高, M蛋白阴性。皮肤活检示肾小球样血管瘤, 肾活检表现为内皮细胞病及小管间质损害, 淋巴结活检诊断为Castleman病。加用足量泼尼松和环磷酰胺后, 病情迅速缓解, 肾功能恢复正常。
-
关键词:
- Castleman病 /
- POEMS综合征 /
- 急性肾损伤 /
- 腹腔积液 /
- 肾小球样血管瘤
Abstract: Castleman disease and POEMS syndrome are both rare diseases, and there is a close relationship between each other. A#60hough these two diseases have been investigated for decades, a comprehensive understanding of renal manifestations is still lacking. We reported a 44-year-old man who suffered from refractory ascites initially, and then developed renal insufficiency and lower limb edema. Physical examination at admission indicated mu#60iple hemangioma in the zone of neck and chest. There was a significant elevation in inflammatory indices and serum vascular endothelial growth factor, while the monoclonal protein was negative. The lymph node biopsy showed Castleman disease; and the skin biopsy showed glomeruloid hemangioma. Renal biopsy demonstrated endotheliopathy and tubular-interstitial injury. He was diagnosed with Castleman disease; and after the treatment with high dose glucocorticoid and immunosuppressants, the disease had been relieved rapidly and the renal function returned normal.-
Key words:
- Castleman disease /
- POEMS syndrome /
- acute kidney injury /
- ascites /
- glomeruloid hemangioma
-
表 1 POEMS综合征梅奥诊断标准(2007年)
标准 内容 强制性主要标准 多发性神经病(典型为脱髓鞘病变) 单克隆浆细胞增殖性疾病(几乎皆为λ) 其他主要标准 Castleman病 硬化性骨损害 血清/血浆血管内皮生长因子升高 次要标准 器官肿大(脾肿大、肝肿大或淋巴结肿大) 内分泌异常(肾上腺、甲状腺、垂体、性腺、甲状旁腺、胰腺) 血管外容量超负荷(水肿、胸腔积液或腹腔积液) 皮肤改变(色素沉着、多毛、肾小球样毛细血管瘤、多血症、紫绀、潮红、指甲发白) 视乳头水肿 红细胞增多, 血小板增多 其他症状及体征 杵状指, 体重下降, 多汗, 肺动脉高压/限制性肺部疾病, 血栓倾向, 腹泻, VB12水平降低 注:明确诊断需满足2条强制性主要标准,1条其他主要标准,1条次要标准 -
[1] Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome:definitions and long-term outcome[J]. Blood, 2003, 101:2496-2506. doi: 10.1182/blood-2002-07-2299 [2] Dispenzieri A. POEMS syndrome[J]. Blood Rev, 2007, 21:285-299. doi: 10.1016/j.blre.2007.07.004 [3] Herrada J, Cabanillas F, Rice L, et al. The clinical behavior of localized and multicentric Castleman disease[J]. Ann Intern Med, 1998, 128:657-662. doi: 10.7326/0003-4819-128-8-199804150-00010 [4] Chronowski GM, Ha CS, Wilder RB, et al. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy[J]. Cancer, 2001, 92:670-676. doi: 10.1002/1097-0142(20010801)92:3<670::AID-CNCR1369>3.0.CO;2-Q [5] Zhang L, Li J. Pathogenesis of Castleman's Disease[J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2016, 38:118-121. http://www.ncbi.nlm.nih.gov/pubmed/26956866 [6] Fajgenbaum DC, van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease:novel insights into biology, pathogenesis, and therapy[J]. Blood, 2014, 123:2924-2933. doi: 10.1182/blood-2013-12-545087 [7] Dispenzieri A. POEMS syndrome:2014 update on diagnosis, risk-stratification, and management[J]. Am J Hematol, 2014, 89:214-223. http://europepmc.org/abstract/MED/22806697 [8] Dispenzieri A, Armitage JO, Loe MJ, et al. The clinical spectrum of Castleman's disease[J]. Am J Hematol, 2012, 87:997-1002. doi: 10.1002/ajh.23291 [9] Dispenzieri A. POEMS syndrome:update on diagnosis, risk-stratification, and management[J]. Am J Hematol, 2015, 90:951-962. doi: 10.1002/ajh.24171 [10] Xu D, Lv J, Dong Y, et al. Renal involvement in a large cohort of Chinese patients with Castleman disease[J]. Nephrol Dial Transplant, 2012, 27 Suppl 3:iii119-iii125. http://www.ncbi.nlm.nih.gov/pubmed/21602182 [11] Zhang L, Li Z, Cao X, et al. Clinical spectrum and survival analysis of 145 cases of HIV-negative Castleman's disease:renal function is an important prognostic factor[J]. Sci Rep, 2016, 6:23831. doi: 10.1038/srep23831